Barchart.com
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier to get Screeners that run automatically with the results emailed to you! FREE 30 Day Trial
Menu
Stocks | Futures | Watchlist | More
 
or
Watchlist | Portfolio
Site News
Contact
Market:

Pharmadrug Inc (LMLLF)

Pharmadrug Inc (LMLLF)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Notes
Alerts
Watch
Help
Go To:
PharmaDrug Provides Forward Plan to Move Its Patent Pending Process and Formulation of Pharmaceutical Grade Biosynthetic Cocaine Through Development into Commercialization Newsfile - Mon May 13, 7:08AM CDT

Toronto, Ontario--(Newsfile Corp. - May 13, 2024) - PharmaDrug Inc. (CSE: PHRX) (OTC Pink: LMLLF) ("PharmaDrug" or the "Company"), a specialty pharmaceutical company focused on the research, development...

LMLLF : 0.0233 (+12.02%)
PHRX.CN : 0.0350 (+16.67%)
PharmaDrug Announces Director Appointment and Resignation Newsfile - Thu May 2, 3:56PM CDT

Toronto, Ontario--(Newsfile Corp. - May 2, 2024) - PharmaDrug Inc. (CSE: PHRX) (OTC Pink: LMLLF) ("PharmaDrug" or the "Company"), a specialty pharmaceutical company focused on the research, development...

LMLLF : 0.0233 (+12.02%)
PHRX.CN : 0.0350 (+16.67%)
PharmaDrug's Sairiyo Therapeutics Completes Clinical and Regulatory Package for Phase 1 Study of Patented Reformulated Cepharanthine Newsfile - Wed May 1, 7:56AM CDT

Toronto, Ontario--(Newsfile Corp. - May 1, 2024) - PharmaDrug Inc. (CSE: PHRX) (OTC Pink: LMLLF) ("PharmaDrug" or the "Company"), a specialty pharmaceutical company focused on the research, development...

LMLLF : 0.0233 (+12.02%)
PHRX.CN : 0.0350 (+16.67%)
PharmaDrug's SecureDose Announces the Advancement of Process Development of Its Biosynthetic Formulation of Pharmaceutical Grade Cocaine Newsfile - Tue Apr 16, 7:52AM CDT

Victoria's Chiral Labs to lead development of novel cocaine manufacturing processToronto, Ontario--(Newsfile Corp. - April 16, 2024) - PharmaDrug Inc. (CSE: PHRX) (OTC Pink: LMLLF) ("PharmaDrug" or the...

LMLLF : 0.0233 (+12.02%)
PHRX.CN : 0.0350 (+16.67%)
PharmaDrug's SecureDose Announces Filing of US Provisional Patent for Manufacturing Method for Biosynthetic Pharmaceutical Grade Cocaine Newsfile - Wed Mar 13, 6:32AM CDT

Toronto, Ontario--(Newsfile Corp. - March 13, 2024) - PharmaDrug Inc. (CSE: PHRX) (OTC PINK: LMLLF) ("PharmaDrug" or the "Company"), a specialty pharmaceutical company focused on the research, development...

LMLLF : 0.0233 (+12.02%)
PHRX.CN : 0.0350 (+16.67%)
PharmaDrug Appoints Current Board Member Dr. David Kideckel as Chairman Newsfile - Tue Feb 27, 7:06AM CST

Toronto, Ontario--(Newsfile Corp. - February 27, 2024) - PharmaDrug Inc. (CSE: PHRX) (OTC Pink: LMLLF) ("PharmaDrug" or the "Company"), a specialty pharmaceutical company focused on the research, development...

LMLLF : 0.0233 (+12.02%)
PHRX.CN : 0.0350 (+16.67%)
PharmaDrug's Sairiyo Successfully Demonstrates Ability to Manufacture Cepharanthine (PD-001) for Human Clinical Studies Newsfile - Wed Feb 14, 7:34AM CST

Company to pursue regulatory filing for Phase I/II clinical studyToronto, Ontario--(Newsfile Corp. - February 14, 2024) - PharmaDrug Inc. (CSE: PHRX) (OTC Pink: LMLLF) ("PharmaDrug" or the "Company"),...

LMLLF : 0.0233 (+12.02%)
PHRX.CN : 0.0350 (+16.67%)
PharmaDrug Inc. Engages Investor Relations and Marketing Service Providers Newsfile - Mon Feb 12, 7:50AM CST

Toronto, Ontario--(Newsfile Corp. - February 12, 2024) - PharmaDrug Inc. (CSE: PHRX) (OTC Pink: LMLLF) ("PharmaDrug" or the "Company"), today announced that it has entered into (i) a marketing and distribution...

LMLLF : 0.0233 (+12.02%)
PHRX.CN : 0.0350 (+16.67%)
PharmaDrug Inc. Announces Successful Closing of Non-Brokered Private Placement Newsfile - Thu Feb 8, 3:34PM CST

Toronto, Ontario--(Newsfile Corp. - February 8, 2024) - PharmaDrug Inc. (CSE: PHRX) (OTC Pink: LMLLF) ("PharmaDrug" or the "Company"), is pleased to announce the closing of its previously announced non-brokered...

LMLLF : 0.0233 (+12.02%)
PHRX.CN : 0.0350 (+16.67%)
PharmaDrug Announces Share Consolidation and Change to Chief Financial Officer Newsfile - Fri Oct 20, 2023

Toronto, Ontario--(Newsfile Corp. - October 20, 2023) - PharmaDrug Inc. (CSE: PHRX) (OTCQB: LMLLF) ("PharmaDrug" or the "Company"), announced today that it will be proceeding with the consolidation of...

LMLLF : 0.0233 (+12.02%)
PHRX.CN : 0.0350 (+16.67%)

Barchart Exclusives

This Wannabe Dividend Aristocrat Looks Cheap After the Crash: Time to Buy? Barchart - Tue May 14, 6:30PM CDT
Starbucks stock plunged following its fiscal Q2 earnings earlier this month. The stock has a healthy dividend yield of nearly 3%, and looks on track to become a dividend aristocrat. Is SBUX stock a buy now? Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar

[[ data.userDate ]]
[[ data.eventTime | date: 'EEE, MMM dd, yyyy h:mm a' ]] [[ zone ]]
Reserve Your Spot